Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death

Michael D. Onken, Lori A. Worley, Justis P. Ehlers, J. William Harbour

Research output: Contribution to journalArticle

418 Citations (Scopus)

Abstract

Melanomas are notoriously difficult to classify because of a lack of discrete clinical and pathological stages. Here, we show that primary uveal melanomas surprisingly cluster into two distinct molecular classes based on gene expression profile. Genes that discriminate class 1 (low-grade) from class 2 (high-grade) include highly significant clusters of down-regulated genes on chromosome 3 and up-regulated genes on chromosome 8q, which is consistent with previous cytogenetic studies. A three-gene signature allows biopsy-size tumor samples to be assigned accurately to tumor classes using either array or PCR platforms. Most importantly, this molecular classification strongly predicts metastatic death and outperforms other clinical and pathological prognostic indicators. These studies offer new insights into melanoma pathogenesis, and they provide a practical foundation for effective clinical predictive testing.

Original languageEnglish
Pages (from-to)7205-7209
Number of pages5
JournalCancer Research
Volume64
Issue number20
DOIs
StatePublished - Oct 15 2004
Externally publishedYes

Fingerprint

Gene Expression Profiling
Genes
Melanoma
Chromosomes, Human, Pair 3
Transcriptome
Cytogenetics
Sample Size
Neoplasms
Chromosomes
Biopsy
Polymerase Chain Reaction
Uveal melanoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. / Onken, Michael D.; Worley, Lori A.; Ehlers, Justis P.; William Harbour, J.

In: Cancer Research, Vol. 64, No. 20, 15.10.2004, p. 7205-7209.

Research output: Contribution to journalArticle

Onken, Michael D. ; Worley, Lori A. ; Ehlers, Justis P. ; William Harbour, J. / Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. In: Cancer Research. 2004 ; Vol. 64, No. 20. pp. 7205-7209.
@article{d063e672b4844cada510e27ed31db9df,
title = "Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death",
abstract = "Melanomas are notoriously difficult to classify because of a lack of discrete clinical and pathological stages. Here, we show that primary uveal melanomas surprisingly cluster into two distinct molecular classes based on gene expression profile. Genes that discriminate class 1 (low-grade) from class 2 (high-grade) include highly significant clusters of down-regulated genes on chromosome 3 and up-regulated genes on chromosome 8q, which is consistent with previous cytogenetic studies. A three-gene signature allows biopsy-size tumor samples to be assigned accurately to tumor classes using either array or PCR platforms. Most importantly, this molecular classification strongly predicts metastatic death and outperforms other clinical and pathological prognostic indicators. These studies offer new insights into melanoma pathogenesis, and they provide a practical foundation for effective clinical predictive testing.",
author = "Onken, {Michael D.} and Worley, {Lori A.} and Ehlers, {Justis P.} and {William Harbour}, J.",
year = "2004",
month = "10",
day = "15",
doi = "10.1158/0008-5472.CAN-04-1750",
language = "English",
volume = "64",
pages = "7205--7209",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

TY - JOUR

T1 - Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death

AU - Onken, Michael D.

AU - Worley, Lori A.

AU - Ehlers, Justis P.

AU - William Harbour, J.

PY - 2004/10/15

Y1 - 2004/10/15

N2 - Melanomas are notoriously difficult to classify because of a lack of discrete clinical and pathological stages. Here, we show that primary uveal melanomas surprisingly cluster into two distinct molecular classes based on gene expression profile. Genes that discriminate class 1 (low-grade) from class 2 (high-grade) include highly significant clusters of down-regulated genes on chromosome 3 and up-regulated genes on chromosome 8q, which is consistent with previous cytogenetic studies. A three-gene signature allows biopsy-size tumor samples to be assigned accurately to tumor classes using either array or PCR platforms. Most importantly, this molecular classification strongly predicts metastatic death and outperforms other clinical and pathological prognostic indicators. These studies offer new insights into melanoma pathogenesis, and they provide a practical foundation for effective clinical predictive testing.

AB - Melanomas are notoriously difficult to classify because of a lack of discrete clinical and pathological stages. Here, we show that primary uveal melanomas surprisingly cluster into two distinct molecular classes based on gene expression profile. Genes that discriminate class 1 (low-grade) from class 2 (high-grade) include highly significant clusters of down-regulated genes on chromosome 3 and up-regulated genes on chromosome 8q, which is consistent with previous cytogenetic studies. A three-gene signature allows biopsy-size tumor samples to be assigned accurately to tumor classes using either array or PCR platforms. Most importantly, this molecular classification strongly predicts metastatic death and outperforms other clinical and pathological prognostic indicators. These studies offer new insights into melanoma pathogenesis, and they provide a practical foundation for effective clinical predictive testing.

UR - http://www.scopus.com/inward/record.url?scp=5644251671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644251671&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-1750

DO - 10.1158/0008-5472.CAN-04-1750

M3 - Article

C2 - 15492234

AN - SCOPUS:5644251671

VL - 64

SP - 7205

EP - 7209

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 20

ER -